• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将oXiris生物吸附滤器纳入连续性肾脏替代治疗(CRRT)用于治疗严重腹部感染及早期撤机相关危险因素分析

Incorporation of oXiris Bioabsorbent Filter into CRRT in the treatment of severe abdominal infections and analysis of associated risk factors for early off-machine.

作者信息

Dong Yanfang, Chen Jieling, Zhang Xiaoli, Wu Shiyu, Li Yiming, Zhang Qiaoxian

机构信息

Department of Emergency Intensive Care Unit, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

Department of Nursing, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

出版信息

Front Public Health. 2025 Jul 30;13:1560587. doi: 10.3389/fpubh.2025.1560587. eCollection 2025.

DOI:10.3389/fpubh.2025.1560587
PMID:40809760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12343586/
Abstract

INTRODUCTION

This study aims to evaluate the impact of oXiris continuous renal-replacement therapy (CRRT) on the prognosis of patients with severe intra-abdominal infections (IAIs) and to analyze potential risk factors for early off-machine of oXiris CRRT during treatment.

METHODS

A total of 49 patients with severe abdominal infections admitted to the intensive care unit of the First Affiliated Hospital of Fujian Medical University from October 2020 to October 2023 were retrospectively analyzed. The patients were divided into a conventional group and an oXiris group. Heart rate, blood lactate level, mean arterial pressure, and total CRRT operation time were observed 72 h before and after CCRT treatment.

RESULTS

When comparing changes in indicators over the 72-h period between the two groups, no significant difference in survival rate was observed between the two groups. D-dimer [per 1 ng/mL increase, odds ratio (OR) = 0.930, 95% confidence interval (CI): 0.866-0.999] was identified as a risk factor for early off-machine. In contrast, prothrombin time (PT, per 1-s increase, OR = 1.117, 95% CI: 1.017-1.226), activated partial thromboplastin time (APTT, per 1-s increase, OR = 1.021, 95% CI: 1.006-1.037), and blood flow velocity (per 1 mL/min increase, OR = 1.027, 95% CI: 1.009-1.046) were found to be protective factors.

CONCLUSION

oXiris CRRT is associated with a better prognosis in the treatment of severe abdominal infections. APTT, PT, D-dimer, and blood flow velocity are associated with early off-machine during oXiris CRRT.

摘要

引言

本研究旨在评估oXiris连续性肾脏替代治疗(CRRT)对严重腹腔内感染(IAIs)患者预后的影响,并分析治疗期间oXiris CRRT早期撤机的潜在危险因素。

方法

回顾性分析2020年10月至2023年10月福建医科大学附属第一医院重症监护病房收治的49例严重腹腔感染患者。将患者分为传统组和oXiris组。在CCRT治疗前后72小时观察心率、血乳酸水平、平均动脉压和CRRT总操作时间。

结果

比较两组72小时内指标变化时,两组生存率无显著差异。D-二聚体[每增加1 ng/mL,比值比(OR)=0.930,95%置信区间(CI):0.866-0.999]被确定为早期撤机的危险因素。相比之下,凝血酶原时间(PT,每增加1秒,OR=1.117,95%CI:1.017-1.226)、活化部分凝血活酶时间(APTT,每增加1秒,OR=1.021,95%CI:1.006-1.037)和血流速度(每增加1 mL/min,OR=1.027,95%CI:1.009-1.046)被发现是保护因素。

结论

oXiris CRRT在严重腹腔感染治疗中与较好的预后相关。APTT、PT、D-二聚体和血流速度与oXiris CRRT期间的早期撤机有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/b82680a49a42/fpubh-13-1560587-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/bbdcabc71f48/fpubh-13-1560587-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/42a1bc34a615/fpubh-13-1560587-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/18fc37c9110b/fpubh-13-1560587-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/e42ef0038add/fpubh-13-1560587-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/b82680a49a42/fpubh-13-1560587-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/bbdcabc71f48/fpubh-13-1560587-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/42a1bc34a615/fpubh-13-1560587-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/18fc37c9110b/fpubh-13-1560587-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/e42ef0038add/fpubh-13-1560587-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36c7/12343586/b82680a49a42/fpubh-13-1560587-g005.jpg

相似文献

1
Incorporation of oXiris Bioabsorbent Filter into CRRT in the treatment of severe abdominal infections and analysis of associated risk factors for early off-machine.将oXiris生物吸附滤器纳入连续性肾脏替代治疗(CRRT)用于治疗严重腹部感染及早期撤机相关危险因素分析
Front Public Health. 2025 Jul 30;13:1560587. doi: 10.3389/fpubh.2025.1560587. eCollection 2025.
2
COMPARISON OF OXIRIS AND CONVENTIONAL CONTINUOUS RENAL REPLACEMENT THERAPY IN MANAGING SEVERE ABDOMINAL INFECTIONS: IMPACT ON SEPTIC SHOCK MORTALITY.Oxiris与传统连续性肾脏替代疗法在治疗严重腹部感染中的比较:对感染性休克死亡率的影响
Shock. 2024 Oct 1;62(4):529-538. doi: 10.1097/SHK.0000000000002437. Epub 2024 Aug 14.
3
Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis.吸附型 oXiris 滤器连续肾脏替代治疗可能与脓毒症 28 天死亡率降低相关:系统评价和荟萃分析。
Crit Care. 2023 Jul 9;27(1):275. doi: 10.1186/s13054-023-04555-x.
4
Reduction Rate of Uric Acid in Blood during Continuous Renal Replacement Therapy for Acute Kidney Injury: A Multicenter Retrospective Observational Study.急性肾损伤持续肾脏替代治疗期间血尿酸的降低率:一项多中心回顾性观察研究
Blood Purif. 2025;54(2):83-92. doi: 10.1159/000542329. Epub 2024 Oct 29.
5
[Clinical study on the effect of glycosaminoglycans on vascular endothelial glycocalyx in sepsis].[糖胺聚糖对脓毒症血管内皮糖萼影响的临床研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025 Jun;37(6):527-534. doi: 10.3760/cma.j.cn121430-20240725-00634.
6
A multicentre, randomised controlled clinical trial evaluating the effect of the adsorptive filter oXiris on haemodynamics in abdominal septic shock patients requiring continuous renal replacement therapy (Oxiris for Abdominal SEptic Shock study).一项多中心随机对照临床试验,评估吸附性滤器oXiris对需要持续肾脏替代治疗的腹部感染性休克患者血流动力学的影响(腹部感染性休克的oXiris研究)
BMJ Open. 2025 Jul 8;15(7):e094792. doi: 10.1136/bmjopen-2024-094792.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
The role of a "volume sparing" strategy in kidney replacement therapy of AKI: a retrospective single-center study.“容量节约”策略在急性肾损伤肾脏替代治疗中的作用:一项回顾性单中心研究。
J Nephrol. 2025 Jan;38(1):235-241. doi: 10.1007/s40620-024-02142-z. Epub 2025 Jan 9.
9
Intervention measures to improve the filter life of continuous renal replacement therapy in critically ill patients-A systematic review.改善危重症患者连续性肾脏替代治疗滤器使用寿命的干预措施——一项系统评价
Nurs Crit Care. 2025 Jul;30(4):e13225. doi: 10.1111/nicc.13225. Epub 2024 Dec 9.
10
Evaluation of anticoagulant methods in newborns undergoing continuous renal replacement therapy: what is the optimum method?接受持续肾脏替代治疗的新生儿抗凝方法评估:最佳方法是什么?
Eur J Pediatr. 2025 Jul 9;184(8):473. doi: 10.1007/s00431-025-06314-2.

本文引用的文献

1
Extracorporeal therapies in sepsis: a comprehensive review of the Selective Cytopheretic Device, Polymyxin B and Seraph cartridges.脓毒症的体外治疗:对选择性细胞去除装置、多粘菌素B和Seraph柱的全面综述
Ren Fail. 2025 Dec;47(1):2459349. doi: 10.1080/0886022X.2025.2459349. Epub 2025 Feb 17.
2
Intra-abdominal infections survival guide: a position statement by the Global Alliance For Infections In Surgery.腹腔内感染生存指南:全球外科感染联盟的立场声明。
World J Emerg Surg. 2024 Jun 8;19(1):22. doi: 10.1186/s13017-024-00552-9.
3
International Consensus Criteria for Pediatric Sepsis and Septic Shock.
国际儿童脓毒症和脓毒性休克共识标准。
JAMA. 2024 Feb 27;331(8):665-674. doi: 10.1001/jama.2024.0179.
4
Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis.吸附型 oXiris 滤器连续肾脏替代治疗可能与脓毒症 28 天死亡率降低相关:系统评价和荟萃分析。
Crit Care. 2023 Jul 9;27(1):275. doi: 10.1186/s13054-023-04555-x.
5
Intra-abdominal Infections.腹腔内感染
Semin Respir Crit Care Med. 2022 Feb;43(1):10-27. doi: 10.1055/s-0041-1741053. Epub 2022 Feb 16.
6
Development and External Validation of a Model for Predicting Sufficient Filter Lifespan in Anticoagulation-Free Continuous Renal Replacement Therapy Patients.开发和外部验证一种预测无抗凝连续性肾脏替代治疗患者足够滤器寿命的模型。
Blood Purif. 2022;51(8):668-678. doi: 10.1159/000519409. Epub 2021 Oct 21.
7
Initial antimicrobial management of sepsis.脓毒症的初始抗菌治疗。
Crit Care. 2021 Aug 26;25(1):307. doi: 10.1186/s13054-021-03736-w.
8
Continuous renal replacement therapy in patients treated with extracorporeal membrane oxygenation.连续性肾脏替代治疗在体外膜肺氧合治疗患者中的应用。
Semin Dial. 2021 Nov;34(6):537-549. doi: 10.1111/sdi.12965. Epub 2021 Mar 25.
9
Efficacy of a joint didactic intervention using the Junta De Andalucía School for Patients method to control prothrombin time in patients taking anticoagulants: protocol for a randomized controlled trial.采用安达卢西亚患者学校方法进行联合教学干预以控制服用抗凝剂患者凝血酶原时间的疗效:一项随机对照试验方案
Trials. 2021 Jan 11;22(1):45. doi: 10.1186/s13063-020-04972-1.
10
Early use of endotoxin absorption by oXiris in abdominal septic shock: A case report.oXiris内毒素吸附在腹部感染性休克中的早期应用:一例报告
Medicine (Baltimore). 2020 Jul 10;99(28):e19632. doi: 10.1097/MD.0000000000019632.